Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus
https://pubmed.ncbi.nlm.nih.gov/22536382/
Aus dem Paper:
Conclusions: These SARS-CoV vaccines all induced antibody and protection against infection with SARS-CoV. However, challenge of mice given any of the vaccines led to occurrence of Th2-type immunopathology suggesting hypersensitivity to SARS-CoV components was induced. Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated.
Ich frage mich ob hinsichtlich der og Problematik ausreichend getestet wurde.
Das Posting wurde vom Benutzer editiert (10.02.2021 02:19).